NM-2201

NM-2201
Systematic (IUPAC) name
	naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate
Clinical data
Legal status	CA: Schedule II; DE: Anlage II (Prohibited); Illegal in Sweden;
Identifiers
CAS Number	837122-21-7
PubChem	CID: 91864534
ChemSpider	30922478
UNII	CCQ6IR3CU2
Chemical data
Formula	C24H22FNO2
Molecular mass	375.4 g/mol
	SMILES FCCCCCN1C=C(C(OC2=C(C=CC=C3)C3=CC=C2)=O)C4=CC=CC=C41 ;
	InChI InChI=1S/C24H22FNO2/c25-15-6-1-7-16-26-17-21(20-12-4-5-13-22(20)26)24(27)28-23-14-8-10-18-9-2-3-11-19(18)23/h2-5,8-14,17H,1,6-7,15-16H2 ; Key:PRGFSQYZCKCBQO-UHFFFAOYSA-N ;

NM-2201 (also known as CBL-2201) is an indole-based synthetic cannabinoid that presumably has similar properties to the closely related 5F-PB-22 and NNE1, which are both full agonists and unselectively bind to CB₁ and CB₂ receptors with low nanomolar affinity.^[1]^[2]^[3]^[4]

Legal status

NM-2201 is banned in Sweden^[5] and Germany (Anlage II).

This cannabinoid related article is a stub. You can help Wikipedia by expanding it.